Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Bionik Laboratories Corp

Healthcare US BNKL

0.0001USD
0.00(0%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

0.00010.0001
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.00125M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.70987M
  • Revenue TTM1.81M
  • Revenue Per Share TTM0.26
  • Gross Profit TTM 0.99M
  • Diluted EPS TTM-0.72

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -4.94602M -10.40799M -13.62046M -25.01650M -10.55660M
Minority interest - - - - -
Net income -13839.94602M -15.60860M -13.95815M -24.93475M -10.55609M
Selling general administrative 2.93M 2.81M 4.57M 5.98M 5.24M
Selling and marketing expenses 1.98M 1.92M 1.02M 2.17M 2.34M
Gross profit 0.99M 0.95M 0.92M 1.26M 1.62M
Reconciled depreciation 0.06M 0.10M 0.19M 0.38M 0.35M
Ebit -4.82504M -4.77259M -6.15527M -11.24586M -7.29019M
Ebitda -4.77571M -4.38218M -6.03313M -10.86521M -6.94198M
Depreciation and amortization 0.05M 0.39M 0.12M 0.38M 0.35M
Non operating income net other - - - - -
Operating income -4.82504M -4.77259M -6.15527M -11.24586M -7.29019M
Other operating expenses 6.63M 6.05M 7.35M 13.32M 12.73M
Interest expense 0.11M 0.83M 0.41M 0.00000M 3.27M
Tax provision - - - - -
Interest income - - - 0.10M 0.07M
Net interest income -0.10715M -0.82521M -0.40528M 0.00000M -3.26692M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 13835.00M 5.20M 0.34M -0.08175M -0.00051M
Total revenue 1.81M 1.27M 1.19M 2.15M 3.25M
Total operating expenses 5.81M 5.73M 7.08M 12.42M 11.10M
Cost of revenue 0.82M 0.32M 0.27M 0.89M 1.63M
Total other income expense net -0.12098M -5.63540M -7.46518M -13.77064M -3.26641M
Discontinued operations - - - - -
Net income from continuing ops -4.94602M -10.40799M -13.62046M -25.01650M -10.55660M
Net income applicable to common shares -4.94602M -10.40799M -13.62046M -25.01650M -10.55660M
Preferred stock and other adjustments - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 3.36M 4.68M 8.79M 18.52M 30.68M
Intangible assets 0.03M - 0.98M 1.45M 4.43M
Earning assets - - - - -
Other current assets 862603.00M 1.13M 1680557.00M 1.59M 1.37M
Total liab 5.00M 1.75M 5.51M 5.20M 3.27M
Total stockholder equity -1.64059M 2.93M 3.28M 13.32M 27.41M
Deferred long term liab - - - - -
Other current liab 1.39M 0.87M 0.76M 1.65M 1.65M
Common stock 0.00699M 0.00688M 0.00570M 0.00513M 0.00386M
Capital stock 0.00699M 0.00688M 0.00570M 0.00513M 0.00386M
Retained earnings -100.34834M -95.40232M -84.99433M -71.37387M -46.35737M
Other liab 0.30M 0.26M 0.30M 0.42M -
Good will 0.10M 0.00000M 4.28M 11.09M 22.31M
Other assets 0.00869M - - - -
Cash 0.43M 1.99M 0.61M 2.27M 0.45M
Cash and equivalents - - - - -
Total current liabilities 2.31M 1.49M 4.10M 5.20M 3.27M
Current deferred revenue 0.34M 0.31M 0.27M 0.62M 0.47M
Net debt 1.98M -1.99138M 3.11M -0.19091M -0.44678M
Short term debt 0.02M - 2.61M 2.08M -
Short long term debt - - 2.61M 2.08M -
Short long term debt total 2.41M - 3.72M 2.08M -
Other stockholder equity 98.67M 98.29M 88.23M 84.64M 73.72M
Property plant equipment 0.44M 0.09M 0.09M 0.15M 0.19M
Total current assets 2.78M 4.58M 3.43M 5.83M 3.75M
Long term investments - - - - -
Net tangible assets -1.77414M 2.93M -1.97850M 0.78M 0.67M
Short term investments - - - - -
Net receivables 0.45M 0.27M 2.13M 0.91M 2.90M
Long term debt 2.16M - 1.11M - -
Inventory 1.03M 1.19M 0.69M 1.06M 0.41M
Accounts payable 0.56M 0.31M 0.45M 0.86M 1.15M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.03M 0.03M 0.04M 0.04M 0.04M
Additional paid in capital - - - - -
Common stock total equity - - - 0.00513M 0.00386M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.00869M - - - 26.93M
Deferred long term asset charges - - - - -
Non current assets total 0.58M 0.09M 5.35M 12.69M 26.93M
Capital lease obligations 0.26M - - - -
Long term debt total - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -0.22369M -0.01250M - -0.15965M -0.10178M
Change to liabilities 0.34M -0.15046M -0.45194M -0.14347M 0.77M
Total cashflows from investing activities -0.22369M -0.01250M -0.01250M -0.15965M -0.10178M
Net borrowings 2.05M 5.55M 2.96M 11.05M 9.27M
Total cash from financing activities 2.05M 5.55M 2.96M 11.05M 9.27M
Change to operating activities 0.78M 0.66M 0.12M -0.28236M -0.79814M
Net income -4.94602M -10.40799M -13.62046M -25.01650M -10.55660M
Change in cash -1.56399M 1.38M -1.66140M 1.82M -0.06053M
Begin period cash flow 1.99M 0.61M 2.27M 0.45M 0.51M
End period cash flow 0.43M 1.99M 0.61M 2.27M 0.45M
Total cash from operating activities -3.38731M -4.14729M -4.62389M -9.06355M -9.23241M
Issuance of capital stock - - - - -
Depreciation 0.06M 0.10M 0.19M 0.38M 0.35M
Other cashflows from investing activities - - - - -
Dividends paid - - - - 0.00000M
Change to inventory 0.08M -0.54396M 0.33M -0.65378M -0.16824M
Change to account receivables -0.17824M 0.18M 0.40M 0.51M -1.29077M
Sale purchase of stock - - - - -
Other cashflows from financing activities 2.05M 5.55M 2.96M 11.57M 9.32M
Change to netincome 0.48M 6.02M 8.41M 16.14M 2.46M
Capital expenditures 50185.00M 0.01M 0.01M 0.16M 0.10M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.01M 0.14M 0.40M -0.57088M -1.48785M
Stock based compensation 0.38M 0.38M 0.82M 1.78M 1.35M
Other non cash items 0.11M 5.63M 0.41M 0.18M 1.14M
Free cash flow 50181.61M -4.15979M -4.62389M -9.22320M -9.33419M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BNKL
Bionik Laboratories Corp		 - -% 0.0001 - - 0.0007 8.04 3.64 -1.1034
HCA
HCA Healthcare, Inc.		 1.82 0.49% 376.99 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.03 0.27% 11.30 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 - -% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

Bionik Laboratories Corp

80 Coolidge Hill Road, Watertown, MA, United States, 02472

Key Executives

Name Title Year Born
Mr. Richard Paul Russo Jr., CPA CEO, Pres & Director 1980
Mr. Michal Prywata Co-Founder & Director 1991
Mr. Daniel Gonsalves CPA Exec. VP & CFO 1983
Mr. John Smathers Director of Operations NA
Mr. Mark Eiseman Sales Director NA
Mr. Richard Paul Russo Jr., CPA CEO, President & Director 1981
Mr. Daniel Gonsalves CPA Executive VP & CFO 1984

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.